赤天化(600227.SH):擬實施資產置換
格隆匯9月10日丨赤天化(600227.SH)公佈,為聚焦公司化工業務,減少關聯交易,保障化工業務的原材料供應,降低煤炭的採購運輸成本,公司擬新設子公司向花秋礦業收購其持有的花秋二礦採礦權及相關附屬資產。同時,由於上市公司醫藥業務受到國家政策等因素影響,導致醫藥板塊面臨虧損,為了增強上市公司盈利能力,擬向花秋礦業置出聖濟堂製藥及其除大秦醫院以外的全部子公司股權(聖濟堂製藥旗下子公司除大秦醫院以外,尚有貴州水林健康產業有限公司)和中觀生物80%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.